Impaired vasodilatation response to amrinone in the forearm of patients with congestive heart failure: Role of endothelium-derived nitric oxide

Journal of Cardiovascular Pharmacology

Volumn 36, Issue 2, 2000, Pages 188-195

  Sakane, Takeshi ^a   Ishibashi, Yutaka ^a   Shimada, Toshio ^a   Takahashi, Nobuyuki ^a   Sugamori, Takashi ^a   Hirano, Yoshifumi ^a   Ohata, Shuzo ^a   Inoue, Shin Ichi ^a   Nakamura, Ko ^a   Murakami, Yo ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Amrinone; Congestive heart failure; Endothelium Nitric oxide; Vasodilatation

Indexed keywords

ACETYLCHOLINE; AMRINONE; GLYCERYL TRINITRATE; N(G) METHYLARGININE; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITOR;

ADULT; AGED; AORTA VALVE REGURGITATION; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG POTENTIATION; ENDOTHELIUM LESION; FEMALE; FOREARM BLOOD FLOW; HEART DILATATION; HEART EJECTION FRACTION; HEART RATE; HUMAN; MALE; MEDIATOR RELEASE; METABOLIC INHIBITION; MITRAL VALVE REGURGITATION; PRIORITY JOURNAL; VASCULAR RESISTANCE; VASODILATATION;

EID: 0033842562     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200036001-00112     Document Type: Article

References (35)

1. Cardiotonic activity of amrinone-Win 40680 [5-amino-3,4'-bipyridine-6(1H)-one]
2. Positive inotropic effect of amrinone in relation to cyclic nucleotide metabolism in the canine ventricular muscle
3. 2+ uptake and cAMP in smooth muscle
4. Amrinone: Its effect on vascular resistance and capacitance in human subjects
5. Intravenous use of amrinone for the treatment of the failing heart
6. Control of arteriolar resistance in heart failure: Partial attenuation of specific phosphodiesterase inhibitor-mediated vasodilation by digitalis glycosides
7. Amrinone versus conventional therapy in pulmonary hypertensive patients awaiting cardiac transplantation
8. Amrinone therapy for severe pulmonary hypertension and biventricular failure after complicated valvular heart surgery
9. Selective pulmonary and systemic vasodilator effects of amrinone in children: New therapeutic implications
10. Pharmacology of positive inotropic phosphodiesterase III inhibitors
11. Endothelium-dependent relaxation of rat thoracic aorta by amrinone-induced nitric oxide release
12. Lack of contribution of nitric oxide to basal vasomotor tone in heart failure
13. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man
14. The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients
15. Importance of endothelial function in chronic heart failure
16. Selective defect in nitric oxide synthesis may explain the impaired endothelium-dependent vasodilation in patients with essential hypertension
17. In vitro vascular relaxation by new inotropic agents: Relationship to phosphodiesterase inhibition and cyclic nucleotides
18. Amrinone causes vasodilation by both endothelium-dependent and endothelium-independent mechanisms in small pulmonary arteries
19. Comparative vasoactive effects of amrinone on systemic and pulmonary arteries in rabbits
20. Effect of phosphodiesterase inhibitors on human arteries in vitro
21. Role of nitric oxide in systemic hemodynamic responses to dobutamine, epinephrine, and amrinone
22. Endothelial cyclic GMP and cyclic AMP do not regulate the release of endothelium-derived relaxing factor/nitric oxide from bovine aortic endothelial cells
23. Increases in endothelial cyclic AMP levels amplify agonist-induced formation of endothelium-derived relaxing factor (EDRF)
24. Novel signal transduction pathway mediating endothelium-dependent beta-adrenoceptor vasorelaxation in rat thoracic aorta
25. Endothelium-dependent vasodilation is attenuated in patients with heart failure
26. Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure: Role of endothelium-derived vasodilating and vasoconstricting factors
27. Effects of L-arginine on impaired acetylcholine-induced and ischemic vasodilation of the forearm in patients with heart failure
28. Attenuated endothelium-dependent peripheral vasodilation and clinical characteristics in patients with chronic heart failure
29. Endothelial function in chronic congestive heart failure
30. Increased nitric oxide production in heart failure
31. A post-receptor defect of adenylyl cyclase in severely failing myocardium from children with congenital heart disease
32. Effect of local intra-arterial N(G)-monomethyl-L-arginine in patients with hypertension: The nitric oxide dilator mechanism appears abnormal
33. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension
34. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus
35. The acute pharmacokinetics and pharmacodynamics of amrinone in pediatric patients